344860 — Innogene Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeMicro CapFalling Star

Annual cashflow statement for Innogene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	2,258	1,339	1,396	945	288
Depreciation
Amortisation
Non-Cash Items	132	197	164	-131	-222
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-435	-1,175	460	-230	401
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	2,185	597	2,251	811	709
Capital Expenditures	-4.81	-34.4	-47.8	-39.6	-293
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,500	-366	-10,023	-282	2,904
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-1,505	-401	-10,071	-322	2,611
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-83.7	-111	7,729	-533	-2,998
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	597	84.6	-91.3	-44	322